相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Design, synthesis, and biological evaluation of carbamate derivatives of N-salicyloyl tryptamine as multifunctional agents for the treatment of Alzheimer's disease
Dan Liu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)
Pleiotropic prodrugs: Design of a dual butyrylcholinesterase inhibitor and 5-HT6 receptor antagonist with therapeutic interest in Alzheimer's disease
Francois-Xavier Toublet et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Development and crystallography-aided SAR studies of multifunctional BuChE inhibitors and 5-HT6R antagonists with β-amyloid anti-aggregation properties
Tomasz Wichur et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Alzheimer's disease
Philip Scheltens et al.
LANCET (2021)
Utilizing the CF2H moiety as a H-bond-donating group in drug discovery
Yossi Zafrani et al.
FUTURE MEDICINAL CHEMISTRY (2020)
Synergy between amyloid-β and tau in Alzheimer's disease
Marc Aurel Busche et al.
NATURE NEUROSCIENCE (2020)
A dual-acting 5-HT6 receptor inverse agonist/MAO-B inhibitor displays glioprotective and pro-cognitive properties
Vittorio Canale et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Development of Multifunctional Molecules as Potential Therapeutic Candidates for Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis in the Last Decade
Masha G. Savelieff et al.
CHEMICAL REVIEWS (2019)
CF2H, a Functional Group-Dependent Hydrogen-Bond Donor: Is It a More or Less Lipophilic Bioisostere of OH, SH, and CH3?
Yossi Zafrani et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
2-Aminoimidazole-based antagonists of the 5-HT6 receptor - A new concept in aminergic GPCR ligand design
Adam S. Hogendorf et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
The Use of Antipsychotic Drugs for Treating Behavioral Symptoms in Alzheimer's Disease
Valeria Calsolaro et al.
FRONTIERS IN PHARMACOLOGY (2019)
Alzheimer's disease
C. A. Lane et al.
EUROPEAN JOURNAL OF NEUROLOGY (2018)
Novel non-sulfonamide 5-HT6 receptor partial inverse agonist in a group of imidazo[4,5-b]pyridines with cognition enhancing properties
David Vanda et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease Three Randomized Clinical Trials
Alireza Atri et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Restoration of Physiological Expression of 5-HT6 Receptor into the Primary Cilia of Null Mutant Neurons Lengthens Both Primary Cilia and Dendrites
Atom J. Lesiak et al.
MOLECULAR PHARMACOLOGY (2018)
Serotonin 5-HT6 Receptor Antagonists in Alzheimer's Disease: Therapeutic Rationale and Current Development Status
Hilda Ferrero et al.
CNS DRUGS (2017)
Novel 3-(1,2,3,6-Tetrahydropyridin-4-yI)-1H-indole-Based Multifunctional Ligands with Antipsychotic-Like, Mood-Modulating, and Procognitive Activity
Adam Bucki et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Difluoromethyl Bioisostere: Examining the Lipophilic Hydrogen Bond Donor Concept
Yossi Zafrani et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Discovery and Development of 1-[(2-Bromophenyl)sulfony1]-5methoxy-3-[(4-methyl-1-piperazinyl)methy1]-1H-indole Dimesylate Monohydrate (SUVN-502): A Novel, Potent, Selective and Orally Active Serotonin 6 (5-HT6) Receptor Antagonist for Potential Treatment of Alzheimer's Disease
Ramakrishna Nirogi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
CF2H, a Hydrogen Bond Donor
Chanan D. Sessler et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2017)
Antagonism of the 5-HT6 receptor - Preclinical rationale for the treatment of Alzheimer's disease
Inge E. M. de Jong et al.
NEUROPHARMACOLOGY (2017)
Agonist E-6837 and antagonist SB-271046 of 5-HT6 receptors both reverse the depressive-like effect induced in mice by subchronic ketamine administration
Jose E. Suarez-Santiago et al.
BEHAVIOURAL PHARMACOLOGY (2017)
Novel 1H-Pyrrolo[3,2-c]quinoline Based 5-HT6 Receptor Antagonists with Potential Application for the Treatment of Cognitive Disorders Associated with Alzheimer's Disease
Katarzyna Grychowska et al.
ACS CHEMICAL NEUROSCIENCE (2016)
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II-III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
Yu Zhou et al.
CHEMICAL REVIEWS (2016)
Fluorination methods in drug discovery
Damian E. Yerien et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2016)
Serotonin: A New Hope in Alzheimer's Disease?
Sylvie Claeysen et al.
ACS CHEMICAL NEUROSCIENCE (2015)
Fluorine in Drug Design: A Case Study with Fluoroanisoles
Li Xing et al.
CHEMMEDCHEM (2015)
Serotonin 5-HT6 Receptor Antagonists for the Treatment of Cognitive Deficiency in Alzheimer's Disease
Bellinda Benhamu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Therapeutics of Alzheimer's disease: Past, present and future
R. Anand et al.
NEUROPHARMACOLOGY (2014)
The procognitive effects of 5-HT6 receptor ligands in animal models of schizophrenia
Agnieszka Nikiforuk
REVIEWS IN THE NEUROSCIENCES (2014)
Current and future treatments for Alzheimer's disease
Konstantina G. Yiannopoulou et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2013)
5-HT6 receptor agonists and antagonists enhance learning and memory in a conditioned emotion response paradigm by modulation of cholinergic and glutamatergic mechanisms
S. Woods et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
5-HT6 receptor and cognition
Xabier Codony et al.
CURRENT OPINION IN PHARMACOLOGY (2011)
Fluorine in medicinal chemistry
Sophie Purser et al.
CHEMICAL SOCIETY REVIEWS (2008)
The many roles for fluorine in medicinal chemistry
William K. Hagmann
JOURNAL OF MEDICINAL CHEMISTRY (2008)
The selective 5-HT6 receptor antagonists SB-271046 and SB-399885 potentiate NCAM PSA immunolabeling not neurogenesis, in the hippocampal of dentate granule cells, but formation of mature Wistar rats
Andrew G. Foley et al.
NEUROPHARMACOLOGY (2008)
An update on the role of the 5-hydroxytryptamine6 receptor in cognitive function
Kevin C. F. Fone
NEUROPHARMACOLOGY (2008)
Lack of localization of 5-HT6 receptors on cholinergic neurons:: implication of multiple neurotransmitter systems in 5-HT6 receptor-mediated acetylcholine release
Beatriz Marcos et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
Memantine - A review of its use in Alzheimer's disease
Dean M. Robinson et al.
DRUGS (2006)
Cholinesterase inhibitors: new roles and therapeutic alternatives
E Giacobini
PHARMACOLOGICAL RESEARCH (2004)
Characterization of SB-271046:: A potent, selective and orally active 5-HT6 receptor antagonist
C Routledge et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
分享论文
